BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND MSH2, COCA1, 4436, ENSG00000095002, HNPCC, FCC1, HNPCC1, P43246 AND Prognosis
13 results:

  • 1. MMR markers correlate with clinical outcome in patients with esophageal squamous cell carcinoma.
    Yamauchi T; Fujishima F; Tsunokake J; Kunimitsu A; Akaishi R; Ozawa Y; Fukutomi T; Okamoto H; Sato C; Taniyama Y; Kamei T; Ichinohasama R; Sasano H
    Int J Biol Markers; 2023 Jun; 38(2):105-113. PubMed ID: 37009661
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The Effect of Tobacco Smoke
    Doukas SG; Vageli DP; Doukas PG; Nikitovic D; Tsatsakis A; Judson BL
    Curr Oncol; 2022 Aug; 29(8):5531-5549. PubMed ID: 36005175
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Fusobacterium nucleatum impairs DNA mismatch repair and stability in patients with squamous cell carcinoma of the head and neck.
    Hsueh CY; Lau HC; Huang Q; Gong H; Sun J; Cao P; Hu C; Zhang M; Tao L; Zhou L
    Cancer; 2022 Sep; 128(17):3170-3184. PubMed ID: 35789992
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Correlation of mismatch repair deficiency with clinicopathological features and programmed death-ligand 1 expression in thyroid carcinoma.
    Qiao PP; Tian KS; Han LT; Ma B; Shen CK; Zhao RY; Zhang Y; Wei WJ; Chen XP
    Endocrine; 2022 Jun; 76(3):660-670. PubMed ID: 35366156
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Mismatch Repair Proteins in Oropharyngeal Squamous Cell Carcinoma: A Retrospective Observational Study.
    de Oliveira Filho OV; Dantas TS; de Lima Silva-Fernandes IJ; Saldanha Cunha MDPS; Alves APNN; Mota MRL; de Barros Silva PG; Sousa FB
    Head Neck Pathol; 2021 Sep; 15(3):803-816. PubMed ID: 33501557
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The Effect of NNK, A Tobacco Smoke Carcinogen, on the miRNA and Mismatch DNA Repair Expression Profiles in Lung and head and neck Squamous cancer Cells.
    Doukas SG; Vageli DP; Lazopoulos G; Spandidos DA; Sasaki CT; Tsatsakis A
    Cells; 2020 Apr; 9(4):. PubMed ID: 32326378
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Specificities of carcinomas in adolescents and young adults].
    Fresneau B; Dourthe ME; Jouin A; Laurence V; de Lambert G; Colas C; Coret M; Laprie A; Rebours C; Orbach D; Demoor-Goldschmidt C
    Bull Cancer; 2017 Mar; 104(3):267-280. PubMed ID: 27989630
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Association between genetic polymorphisms in DNA mismatch repair-related genes with risk and prognosis of head and neck squamous cell carcinoma.
    Nogueira GA; Lourenço GJ; Oliveira CB; Marson FA; Lopes-Aguiar L; Costa EF; Lima TR; Liutti VT; Leal F; Santos VC; Rinck-Junior JA; Lima CS
    Int J Cancer; 2015 Aug; 137(4):810-8. PubMed ID: 25598504
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Low expression of msh2 DNA repair protein is associated with poor prognosis in head and neck squamous cell carcinoma.
    Pereira CS; Oliveira MV; Barros LO; Bandeira GA; Santos SH; Basile JR; GuimarĂ£es AL; De Paula AM
    J Appl Oral Sci; 2013; 21(5):416-21. PubMed ID: 24212987
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. msh2 promoter hypermethylation in circulating tumor DNA is a valuable predictor of disease-free survival for patients with esophageal squamous cell carcinoma.
    Ling ZQ; Zhao Q; Zhou SL; Mao WM
    Eur J Surg Oncol; 2012 Apr; 38(4):326-32. PubMed ID: 22265839
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival.
    Azad AK; Bairati I; Samson E; Cheng D; Mirshams M; Qiu X; Savas S; Waldron J; Wang C; Goldstein D; Xu W; Meyer F; Liu G
    Clin Cancer Res; 2012 Jan; 18(1):196-206. PubMed ID: 22076708
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Deficiency of hMLH1 and hmsh2 expression is a poor prognostic factor in esophageal squamous cell carcinoma.
    Uehara H; Miyamoto M; Kato K; Cho Y; Kurokawa T; Murakami S; Fukunaga A; Ebihara Y; Kaneko H; Hashimoto H; Murakami Y; Shichinohe T; Kawarada Y; Itoh T; Okushiba S; Kondo S; Katoh H
    J Surg Oncol; 2005 Nov; 92(2):109-15. PubMed ID: 16231369
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Esophageal, gastric and colorectal tumors].
    Stolte M
    Verh Dtsch Ges Pathol; 2001; 85():208-11. PubMed ID: 11894400
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.